cox num inhibitors story greed deception death pubmed ncbi abstract num drug manufacturers introduced class nsaids called cox num inhibitors coxibs drugs avidly promoted directly consumers bestsellers start arthritis sufferers eager medications eased joint pain risk causing gastrointestinal pain bleeding side-effects year introduction doctors wrote num million prescriptions celecoxib celebrex rofecoxib vioxx celebrex sixth best-selling drug sales num billion debut num vioxx sales num billion num coxibs increase risk heart attacks strokes price usa obscene manufacturers faced possibly complicit toothless bloodless fda maneuvering fleece patients reflect attitudes thought belong tobacco industry fortunately safe active alternatives exist 
